Kayne Anderson Rudnick Investment Management
BCAB

Kayne Anderson Rudnick Investment Management’s BIOATLA INC BCAB Stock Holding History

Kayne Anderson Rudnick Investment Management’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3
Closed -$1K – 608
2022
Q1 		$1K Buy
+3
New +$1.25K ﹤0.01% 617

Other funds holding BCAB

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management's BCAB Position: Q2 2022 in Review

Kayne Anderson Rudnick Investment Management sold out of BIOATLA INC (BCAB) in Q2 2022, closing a stake of 3 shares — an estimated $1K sold.

Kayne Anderson Rudnick Investment Management first reported a position in BCAB in Q1 2022 and held it in 1 quarter. The position peaked at $1K in Q1 2022. 76 funds tracked by Wall St. Rank hold BCAB as of Q2 2022.

  • Kayne Anderson Rudnick Investment Management reported no remaining BIOATLA INC position as of Q2 2022 after selling out during the quarter.
  • Kayne Anderson Rudnick Investment Management sold 3 BIOATLA INC shares in Q2 2022, an estimated $1K.
  • Kayne Anderson Rudnick Investment Management first reported a position in BIOATLA INC in Q1 2022 and held it in 1 quarter.
  • Kayne Anderson Rudnick Investment Management's BIOATLA INC position peaked at $1K in Q1 2022.
  • 76 funds tracked by Wall St. Rank held BIOATLA INC as of Q2 2022.

Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q2 2022, filed 12 Aug 2022.